These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35780939)

  • 1. Novel inflammasome and oxidative modulators in Parkinson's disease: A prospective study.
    Roy A; Banerjee R; Choudhury S; Chatterjee K; Mondal B; Dey S; Kumar H
    Neurosci Lett; 2022 Aug; 786():136768. PubMed ID: 35780939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.
    Fan Z; Pan YT; Zhang ZY; Yang H; Yu SY; Zheng Y; Ma JH; Wang XM
    J Neuroinflammation; 2020 Jan; 17(1):11. PubMed ID: 31915018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson's Disease.
    Li Y; Xia Y; Yin S; Wan F; Hu J; Kou L; Sun Y; Wu J; Zhou Q; Huang J; Xiong N; Wang T
    Front Immunol; 2021; 12():719807. PubMed ID: 34691027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease.
    Lee JH; Kim HJ; Kim JU; Yook TH; Kim KH; Lee JY; Yang G
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X7 receptor/NLRP3 inflammasome complex and α-synuclein in peripheral blood mononuclear cells: a prospective study in neo-diagnosed, treatment-naïve Parkinson's disease.
    Solini A; Rossi C; Santini E; Giuntini M; Raggi F; Parolini F; Biancalana E; Del Prete E; Bonuccelli U; Ceravolo R
    Eur J Neurol; 2021 Aug; 28(8):2648-2656. PubMed ID: 33991356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease.
    Zhang M; He Q; Chen G; Li PA
    Neurodegener Dis; 2020; 20(2-3):73-83. PubMed ID: 33176317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
    Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
    Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genkwanin suppresses MPP
    Li Q; Zhang P; Cai Y
    Neurotoxicology; 2021 Dec; 87():62-69. PubMed ID: 34481870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The circadian clock protein Rev-erbα provides neuroprotection and attenuates neuroinflammation against Parkinson's disease via the microglial NLRP3 inflammasome.
    Kou L; Chi X; Sun Y; Han C; Wan F; Hu J; Yin S; Wu J; Li Y; Zhou Q; Zou W; Xiong N; Huang J; Xia Y; Wang T
    J Neuroinflammation; 2022 Jun; 19(1):133. PubMed ID: 35668454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-(3,4-Difluorophenyl)-3-(6-methylpyridin-3-yl)-1,2,4-oxadiazole (DDO-7263), a novel Nrf2 activator targeting brain tissue, protects against MPTP-induced subacute Parkinson's disease in mice by inhibiting the NLRP3 inflammasome and protects PC12 cells against oxidative stress.
    Xu LL; Wu YF; Yan F; Li CC; Dai Z; You QD; Jiang ZY; Di B
    Free Radic Biol Med; 2019 Apr; 134():288-303. PubMed ID: 30615919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease.
    Haque ME; Akther M; Jakaria M; Kim IS; Azam S; Choi DK
    Mov Disord; 2020 Jan; 35(1):20-33. PubMed ID: 31680318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NLRP3 inflammasome and glia maturation factor coordinately regulate neuroinflammation and neuronal loss in MPTP mouse model of Parkinson's disease.
    Javed H; Thangavel R; Selvakumar GP; Dubova I; Schwartz N; Ahmed ME; Zaheer S; Kempuraj D; Iyer S; Zaheer A; Khan MM
    Int Immunopharmacol; 2020 Jun; 83():106441. PubMed ID: 32259702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
    Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
    Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome.
    Bai H; Yang B; Yu W; Xiao Y; Yu D; Zhang Q
    Exp Cell Res; 2018 Jan; 362(1):180-187. PubMed ID: 29196167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammasome and α-synuclein in Parkinson's disease: A cross-sectional study.
    Chatterjee K; Roy A; Banerjee R; Choudhury S; Mondal B; Halder S; Basu P; Shubham S; Dey S; Kumar H
    J Neuroimmunol; 2020 Jan; 338():577089. PubMed ID: 31704453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dl-3-n-Butylphthalide Rescues Dopaminergic Neurons in Parkinson's Disease Models by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
    Que R; Zheng J; Chang Z; Zhang W; Li H; Xie Z; Huang Z; Wang HT; Xu J; Jin D; Yang W; Tan EK; Wang Q
    Front Immunol; 2021; 12():794770. PubMed ID: 34925379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-29c-3p inhibits microglial NLRP3 inflammasome activation by targeting NFAT5 in Parkinson's disease.
    Wang R; Li Q; He Y; Yang Y; Ma Q; Li C
    Genes Cells; 2020 Jun; 25(6):364-374. PubMed ID: 32160394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration.
    Lee E; Hwang I; Park S; Hong S; Hwang B; Cho Y; Son J; Yu JW
    Cell Death Differ; 2019 Jan; 26(2):213-228. PubMed ID: 29786072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do peripheral immune and neurotrophic markers correlate with motor severity of Parkinson's disease?
    Roy A; Mondal B; Banerjee R; Choudhury S; Chatterjee K; Dey S; Kumar H
    J Neuroimmunol; 2021 May; 354():577545. PubMed ID: 33756415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.